Do analysts rate RMTI or RVP?

Rockwell Medical presently has a consensus target price of $20.00, indicating a potential upside of 148.14%. Given Rockwell Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend LUCY or RMTI?

Rockwell Medical has a consensus price target of $20.00, suggesting a potential upside of 148.14%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer LUCY or RMTI?

In the previous week, Rockwell Medical had 5 more articles in the media than Innovative Eyewear. MarketBeat recorded 6 mentions for Rockwell Medical and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.00 beat Rockwell Medical's score of -0.77 indicating that Innovative Eyewear is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rockwell Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative

Is RMTI or NXGL more profitable?

Rockwell Medical has a net margin of -7.33% compared to NexGel's net margin of -51.26%. Rockwell Medical's return on equity of -14.03% beat NexGel's return on equity. Company Net Margins Return on Equity Return on Assets Rockwell Medical -7.33% -14.03% -8.90% NexGel -51.26% -121.18% -41.15%

Does the media prefer RMTI or NXGL?

In the previous week, Rockwell Medical had 4 more articles in the media than NexGel. MarketBeat recorded 6 mentions for Rockwell Medical and 2 mentions for NexGel. NexGel's average media sentiment score of 0.46 beat Rockwell Medical's score of -0.77 indicating that NexGel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rockwell Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative NexGel 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Rockwell Medical (RMTI) Competitors

$8.06 +0.15 (+1.90%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$7.95 -0.11 (-1.34%)

As of 09/18/2026 07:56 PM Eastern

Compare

RMTI vs. NEPH, RVP, BMRA, LUCY, and NXGL

Should you buy Rockwell Medical stock or one of its competitors? Rockwell Medical's main competitors and comparable companies include Nephros (NEPH), Retractable Technologies (RVP), Biomerica (BMRA), Innovative Eyewear (LUCY), and NexGel (NXGL). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Rockwell Medical compare to Nephros?

Rockwell Medical (NASDAQ:RMTI) and Nephros (NASDAQ:NEPH) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.

Rockwell Medical presently has a consensus target price of $20.00, indicating a potential upside of 148.14%. Nephros has a consensus target price of $4.00, indicating a potential downside of 7.19%. Given Rockwell Medical's higher possible upside, equities analysts clearly believe Rockwell Medical is more favorable than Nephros.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nephros	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Nephros has a net margin of 8.38% compared to Rockwell Medical's net margin of -7.33%. Nephros' return on equity of 10.60% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Nephros	8.38%	10.60%	8.05%

In the previous week, Rockwell Medical had 6 more articles in the media than Nephros. MarketBeat recorded 6 mentions for Rockwell Medical and 0 mentions for Nephros. Nephros' average media sentiment score of 0.00 beat Rockwell Medical's score of -0.77 indicating that Nephros is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Negative
Nephros	Neutral

Rockwell Medical has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market. Comparatively, Nephros has a beta of 1.55, suggesting that its share price is 55% more volatile than the broader market.

Nephros has lower revenue, but higher earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Nephros, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.47	-$5.31M	-$1.34	N/A
Nephros	$18.79M	2.49	$1.19M	$0.16	26.94

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 41.1% of Nephros shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by insiders. Comparatively, 6.7% of Nephros shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Nephros beats Rockwell Medical on 11 of the 15 factors compared between the two stocks.

How does Rockwell Medical compare to Retractable Technologies?

Rockwell Medical (NASDAQ:RMTI) and Retractable Technologies (NYSE:RVP) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Rockwell Medical presently has a consensus target price of $20.00, indicating a potential upside of 148.14%. Given Rockwell Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Rockwell Medical has a net margin of -7.33% compared to Retractable Technologies' net margin of -41.11%. Rockwell Medical's return on equity of -14.03% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Rockwell Medical has a beta of 1.64, suggesting that its share price is 64% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market.

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Rockwell Medical has higher revenue and earnings than Retractable Technologies. Rockwell Medical is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.47	-$5.31M	-$1.34	N/A
Retractable Technologies	$33.90M	0.64	-$7.01M	-$0.12	N/A

In the previous week, Rockwell Medical had 6 more articles in the media than Retractable Technologies. MarketBeat recorded 6 mentions for Rockwell Medical and 0 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 beat Rockwell Medical's score of -0.77 indicating that Retractable Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Negative
Retractable Technologies	Neutral

Summary

Rockwell Medical beats Retractable Technologies on 11 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Biomerica?

Rockwell Medical (NASDAQ:RMTI) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

Rockwell Medical has a net margin of -7.33% compared to Biomerica's net margin of -84.79%. Rockwell Medical's return on equity of -14.03% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Biomerica	-84.79%	-97.19%	-61.57%

Rockwell Medical currently has a consensus price target of $20.00, suggesting a potential upside of 148.14%. Biomerica has a consensus price target of $9.00, suggesting a potential upside of 258.57%. Given Biomerica's higher probable upside, analysts plainly believe Biomerica is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Rockwell Medical has a beta of 1.64, meaning that its share price is 64% more volatile than the broader market. Comparatively, Biomerica has a beta of 0.37, meaning that its share price is 63% less volatile than the broader market.

In the previous week, Rockwell Medical had 6 more articles in the media than Biomerica. MarketBeat recorded 6 mentions for Rockwell Medical and 0 mentions for Biomerica. Biomerica's average media sentiment score of 0.00 beat Rockwell Medical's score of -0.77 indicating that Biomerica is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Negative
Biomerica	Neutral

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 22.3% of Biomerica shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by company insiders. Comparatively, 18.0% of Biomerica shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Biomerica has lower revenue, but higher earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Biomerica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.47	-$5.31M	-$1.34	N/A
Biomerica	$4.45M	1.74	-$3.78M	-$1.27	N/A

Summary

Rockwell Medical beats Biomerica on 9 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCY) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

Innovative Eyewear has a beta of 2.76, meaning that its stock price is 176% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.64, meaning that its stock price is 64% more volatile than the broader market.

Rockwell Medical has a net margin of -7.33% compared to Innovative Eyewear's net margin of -225.26%. Rockwell Medical's return on equity of -14.03% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innovative Eyewear	-225.26%	-88.90%	-80.34%
Rockwell Medical	-7.33%	-14.03%	-8.90%

Rockwell Medical has a consensus price target of $20.00, suggesting a potential upside of 148.14%. Given Rockwell Medical's stronger consensus rating and higher possible upside, analysts clearly believe Rockwell Medical is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Rockwell Medical had 5 more articles in the media than Innovative Eyewear. MarketBeat recorded 6 mentions for Rockwell Medical and 1 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.00 beat Rockwell Medical's score of -0.77 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rockwell Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative

Rockwell Medical has higher revenue and earnings than Innovative Eyewear. Rockwell Medical is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Eyewear	$2.66M	3.07	-$7.59M	-$1.29	N/A
Rockwell Medical	$69.26M	0.47	-$5.31M	-$1.34	N/A

1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are held by institutional investors. 1.7% of Innovative Eyewear shares are held by insiders. Comparatively, 4.6% of Rockwell Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Rockwell Medical beats Innovative Eyewear on 11 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to NexGel?

Rockwell Medical (NASDAQ:RMTI) and NexGel (NASDAQ:NXGL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.

In the previous week, Rockwell Medical had 4 more articles in the media than NexGel. MarketBeat recorded 6 mentions for Rockwell Medical and 2 mentions for NexGel. NexGel's average media sentiment score of 0.46 beat Rockwell Medical's score of -0.77 indicating that NexGel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
NexGel	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Rockwell Medical presently has a consensus target price of $20.00, indicating a potential upside of 148.14%. NexGel has a consensus target price of $2.00, indicating a potential upside of 652.45%. Given NexGel's higher probable upside, analysts plainly believe NexGel is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
NexGel	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

NexGel has lower revenue, but higher earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.47	-$5.31M	-$1.34	N/A
NexGel	$11.42M	0.23	-$3M	-$0.71	N/A

Rockwell Medical has a beta of 1.64, meaning that its share price is 64% more volatile than the broader market. Comparatively, NexGel has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by company insiders. Comparatively, 19.8% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Rockwell Medical has a net margin of -7.33% compared to NexGel's net margin of -51.26%. Rockwell Medical's return on equity of -14.03% beat NexGel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
NexGel	-51.26%	-121.18%	-41.15%

Summary

Rockwell Medical beats NexGel on 10 of the 16 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RMTI vs. The Competition

Export

Metric	Rockwell Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$32.51M	$5.55B	$7.24B	$13.19B
Dividend Yield	N/A	1.80%	2.57%	12.81%
P/E Ratio	-6.01	25.34	275.49	25.40
Price / Sales	0.47	72.49	646.01	89.45
Price / Cash	N/A	32.64	76.25	51.42
Price / Book	0.86	5.69	10.46	6.33
Net Income	-$5.31M	$151.55M	$3.49B	$358.33M
7 Day Performance	1.26%	0.66%	0.59%	1.12%
1 Month Performance	5.50%	-3.33%	-1.74%	-2.39%
1 Year Performance	-39.40%	6.79%	18.13%	5.35%

Rockwell Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RMTI Rockwell Medical	2.2712 of 5 stars	$8.06 +1.9%	$20.00 +148.1%	-39.4%	$32.51M	$69.26M	N/A	157	News Coverage Analyst Revision High Trading Volume
NEPH Nephros	2.6815 of 5 stars	$4.44 +0.1%	$4.00 -9.8%	+3.1%	$48.16M	$20.72M	27.72	30
RVP Retractable Technologies	N/A	$0.70 +2.5%	N/A	-14.5%	$20.93M	$33.90M	N/A	240
BMRA Biomerica	2.0644 of 5 stars	$2.33 -1.3%	$9.00 +286.3%	-12.8%	$7.20M	$4.45M	N/A	60
LUCY Innovative Eyewear	0.349 of 5 stars	$0.82 -1.3%	N/A	-51.0%	$7.06M	$3.41M	N/A	9

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RMTI) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, RVP, BMRA, LUCY, and NXGL

How does Rockwell Medical compare to Nephros?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Summary

How does Rockwell Medical compare to Biomerica?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Summary

How does Rockwell Medical compare to NexGel?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, RVP, BMRA, LUCY, and NXGL

How does Rockwell Medical compare to Nephros?

Do analysts rate RMTI or NEPH?

Is RMTI or NEPH more profitable?

Does the media favor RMTI or NEPH?

Which has more volatility & risk, RMTI or NEPH?

Which has better earnings and valuation, RMTI or NEPH?

Do institutionals and insiders believe in RMTI or NEPH?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Do analysts rate RMTI or RVP?

Is RMTI or RVP more profitable?

Which has more volatility and risk, RMTI or RVP?

Do insiders & institutionals believe in RMTI or RVP?

Which has better valuation and earnings, RMTI or RVP?

Does the media refer more to RMTI or RVP?

Summary

How does Rockwell Medical compare to Biomerica?

Is RMTI or BMRA more profitable?

Do analysts prefer RMTI or BMRA?

Which has more risk & volatility, RMTI or BMRA?

Does the media refer more to RMTI or BMRA?

Do insiders & institutionals have more ownership in RMTI or BMRA?

Which has preferable valuation & earnings, RMTI or BMRA?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Which has more volatility & risk, LUCY or RMTI?

Is LUCY or RMTI more profitable?

Do analysts recommend LUCY or RMTI?

Does the media prefer LUCY or RMTI?

Which has higher earnings and valuation, LUCY or RMTI?

Do institutionals & insiders hold more shares of LUCY or RMTI?

Summary

How does Rockwell Medical compare to NexGel?

Does the media prefer RMTI or NXGL?

Do analysts prefer RMTI or NXGL?

Which has better valuation and earnings, RMTI or NXGL?

Which has more risk & volatility, RMTI or NXGL?

Do insiders and institutionals believe in RMTI or NXGL?

Is RMTI or NXGL more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools